🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of acetaminophen, asserting the firms hid potential risks that the medication posed to children's neurological development.

This legal action comes a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - alternatively called paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which once produced the medication, the sole analgesic suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he said they "deceived the public by making money from discomfort and marketing drugs regardless of the dangers."

The company says there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These corporations lied for decades, intentionally threatening numerous people to boost earnings," the attorney general, a Republican, declared.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its official site, Kenvue also stated it had "regularly reviewed the applicable studies and there is insufficient valid information that shows a verified association between taking acetaminophen and autism."

Organizations speaking for doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated paracetamol - the key substance in Tylenol - is one of the few options for expectant mothers to manage pain and elevated temperature, which can present serious health risks if left untreated.

"In more than two decades of research on the utilization of paracetamol in gestation, zero credible investigations has conclusively proven that the use of acetaminophen in any stage of pregnancy causes neurodevelopmental disorders in young ones," the association commented.

This legal action mentions current declarations from the former administration in claiming the medication is reportedly hazardous.

Recently, the former president raised alarms from health experts when he advised pregnant women to "struggle intensely" not to consume Tylenol when ill.

The FDA then published an announcement that medical professionals should consider limiting the use of Tylenol, while also declaring that "a proven link" between the medication and autism in minors has not been proven.

Health Secretary Kennedy, who manages the Food and Drug Administration, had vowed in April to undertake "extensive scientific investigation" that would determine the origin of autism in a short period.

But authorities cautioned that identifying a unique factor of autism - considered by experts to be the consequence of a intricate combination of inherited and environmental factors - would prove challenging.

Autism is a category of enduring cognitive variation and disability that affects how individuals perceive and relate to the world, and is diagnosed using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is campaigning for the Senate - claims the manufacturer and J&J "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.

This legal action attempts to require the companies "destroy any commercial messaging" that states acetaminophen is secure for expectant mothers.

This legal action parallels the concerns of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in two years ago.

The court threw out the case, stating research from the plaintiffs' authorities was lacking definitive proof.